Navigation Links
ULURU Discussions to Acquire York Pharma, plc Are Currently Terminated
Date:6/24/2009

ADDISON, Texas, June 24 /PRNewswire-FirstCall/ -- ULURU Inc. (NYSE Amex: ULU) today announced that at this time discussions to acquire York Pharma, plc, a public limited company incorporated under the laws of England and Wales ("York") have been terminated. Previously it had been announced that ULURU intended to proceed with an offer to acquire all of the issued share capital of York, as described in the non-binding offer letter that ULURU and York signed on April 6, 2009. ULURU has notified York that all amounts owing to ULURU under the secured revolving credit facility established pursuant to that certain Note Purchase Agreement dated March 31, 2009 by and between ULURU and York, which amounts total US$1,000,000, plus all accrued but unpaid interest, are due and payable in accordance with the terms of such facility. This revolving credit facility is secured by substantially all of the assets of York and its subsidiaries.

Despite this termination of discussions with York, ULURU remains committed to pursuing strategic opportunities and partnerships in the near future.

About ULURU Inc.:

ULURU Inc. is a specialty pharmaceutical company focused on the development of a portfolio of wound management and oral care products to provide patients and consumers with improved clinical outcomes through controlled delivery utilizing its innovative Nanoflex(TM) Aggregate technology and transmucosal delivery system. For more information about Altrazeal(TM), please visit www.Altrazeal.com. For more information about ULURU Inc., please visit www.uluruinc.com.

This press release contains certain statements that are forward-looking within the meaning of Section 27a of the Securities Act o
'/>"/>

SOURCE ULURU Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. ULURU to Present Clinical Evidence and Advanced Research on Altrazeal at the Society for Advance Wound Care Conference for 2009
2. ULURU Inc. Announces the Filing of a 510k Submission With the FDA for Altrazeal(TM) Silver
3. ULURU Inc. Reports Second Quarter 2008 Financial Results
4. ULURU Inc. Announces Update on Recent Development
5. ULURU Inc. to Present at the 8th World Biomaterials Congress
6. Icahn Asks Amylin to Allow Discussions With Eastbourne
7. Kiwa Bio-Tech in Collaboration Discussions with Beijing Hai Xin Science and Technology Co., Ltd.
8. Barr and Ortho Womens Health & Urology in Discussions to Settle ORTHO TRI-CYCLEN(R) LO Patent Litigation
9. Discussions With FDA on Pixantrone EXTEND (PIX301) Trial Provide Path for NDA Submission
10. Biopure Gives Update on Malaysia Joint Venture Discussions
11. Solon Manufacturing Company Acquires PurFybr Brands; Adds Influenza Virus Diagnostic Swabs to Product Line
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... , HOUSTON, Dec. 3 Jou...has updated its facility to offer patients a secon...along with the LAP-BAND® System that it cur...edure at the facility was performed by surgeon par...9. The patient is reported as doing well. ,, Th...
(Date:12/3/2009)... , PHILADELPHIA, Dec. 3 /PRNewswire-FirstCa...global specialty biopharmaceutical company, today ...ntary market withdrawal of one lot of the Attentio...rana ® . Shire is taking this action because ... may not meet their release liner removal specific...
(Date:12/3/2009)... , NEW DELHI, India, Dec. 3 /PRN...ef Science Officer at Shenzhen Beike Biotechnology...at a conference on High-Risk Diabetic,Foot Care in...na,s leading,stem cell research and regenerative m...zed by the Indian Podiatry Association (IPA), aime...
(Date:12/2/2009)... , NEW YORK, Dec. 2 R...ch report is available in its catalogue: ,, Ca...ve ,, http://www.reportlinker.com/p0164368/Ca...ve.html ,, Incubators are the most critical e...esearch, and other applications for providing a co...
Breaking Biology Technology:JourneyLite of Houston Now Offering Sleeve Gastrectomy 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4
... $14.1 million--, XI,AN, China, Oct. 16 /Xinhua-P...(OTC Bulletin Board: CBEH) ("China Bio Energy" and...istribution of heavy oil and finished oil,products... fuel, announced,that it has completed a $9,000,00...nture that is convertible into 2,465,753 shares of...
...chnology Implant Offers Promising Patient Solution...chnology,Inc., a leader in innovative medical devi...tion of its new biologic inter-body spacer. The,na...lly robust,nano-crystalline hydroxyapatite (HA) an...ere performed at hospitals in Beijing and Suzhou, ...
... A team of researchers from,Intrinsic Bioprobes In...rometry immunoassay for the detection of bioactive...ublished online on Oct. 14 in the journal of,Circu...agues from Scios,Inc. in Fremont, Christ Hospital ...o, the team discovered very low concentration of b...
Other Biology Technology:China Bio Energy Holdings Group Announces Financing and Exercise of Warrants 2China Bio Energy Holdings Group Announces Financing and Exercise of Warrants 3Pioneer(R) Surgical Technology Announces First Human Implants of New nanOss(TM)-Cervical Fusion Device 2Novel Mass Spectrometry-based Assay Reveals Degradation and Low Levels of Bioactive B-type Natriuretic Peptide (BNP) in Patients with Heart Failure 2
(Date:12/2/2009)... first cigarette within minutes after waking up ha... nicotine when processed by the body, than those w...rettes smoked. , "Since cotinine levels appea...suggest that smokers who smoke immediately after w...said researcher Joshua E. Muscat, Ph.D., M.P.H., p...
(Date:12/2/2009)... status did not prompt people participating in a l...screening program to pick up their cigarettes agai...er Epidemiology, Biomarkers & Prevention , a journ.... The December issue contains a special focus on t...d concern in the lung screening community that rea...
(Date:12/2/2009)...rgia College of Veterinary Medicine have made an "...nues for treating Ichthyophthirius multifiliis, or...site that commonly attacks freshwater fish. , Wi... found that Ich harbors two apparently symbiotic i...ally found free-living, and Rickettsia, which are ...
Breaking Biology News(10 mins):Increased nicotine levels detected in those who light-up earlier 2Repeat negative CT scan for lung cancer does not encourage ex-smokers to resume the habit 2UGA researchers lead team in discovery involving devastating freshwater fish parasite, 'Ich' 2UGA researchers lead team in discovery involving devastating freshwater fish parasite, 'Ich' 3US Farms Inc Announces Broker Network Agreement With Sunshine Specialties for Aloe365 Products 58160 1US Farms Inc Announces Broker Network Agreement With Sunshine Specialties for Aloe365 Products 58160 2US Farms Inc Announces Broker Network Agreement With Sunshine Specialties for Aloe365 Products 58160 3Pelosi Remarks at the Congressional Black Caucus Foundations Annual Legislative Conference 58156 1Pelosi Remarks at the Congressional Black Caucus Foundations Annual Legislative Conference 58156 2Pelosi Remarks at the Congressional Black Caucus Foundations Annual Legislative Conference 58156 3Food Addicts Convention Draws 800 Members from 31 States 5 Nations Around the World 58152 1Food Addicts Convention Draws 800 Members from 31 States 5 Nations Around the World 58152 2Food Addicts Convention Draws 800 Members from 31 States 5 Nations Around the World 58152 3
... A potentially fatal species of malaria is being ... disease, thereby putting lives at risk, according...University Malaysia Sarawak. , Researchers in M...ia patients across the country. Using DNA-based te...ients in Sarawak, Malaysian Borneo, were infected ...
... CAMBRIDGE, Mass. - MIT and Italian energy compan...nership. The centerpiece of this collaboration wil...nced solar technologies, from novel photovoltaic m...Eni will also become a Founding Member of the MIT ...of diverse energy research projects at the Institu...
...OSEN, Ill., Jan. 14 Corporate Safe Specialists (C...n. The Company has hired,Larry M. Ladd as National...m/cgi-bin/prnh/20080114/AQM106 ), (Logo: http://..., James Currey, Sales Manager of the Company, sta... further accelerate the growth we,ve seen in,netwo...
Other Biology News:Monkey malaria widespread in humans and potentially fatal 2MIT, Eni announce energy research partnership 2MIT, Eni announce energy research partnership 3Corporate Safe Specialists Announces Addition to Sales Team 2
McCown's Woody Plant Basal Salt Mixture from Sigma-Aldrich
...ing Kit is a very sensitive immunohistochemical to..., containing both anti-von Willebrand Factor and a... variety of species. This AP kit provides a simple... paraffin-embedded sections in human (both CD31 an...
Qproteome Nuclear Subfractionation Kit from QIAGEN
Nutrient Mixture F-12 Ham, Coon's Modification (Ham's F-12 Coon's) from Sigma-Aldrich
Biology Products: